S1P–S1PR2 axis mediates homing of muse cells into damaged heart for long-lasting tissue repair and functional recovery after acute myocardial infarction

Circulation Research

Volumn 122, Issue 8, 2018, Pages 1069-1083

  Yamada, Yoshihisa ^a   Wakao, Shohei ^b   Kushida, Yoshihiro ^b   Minatoguchi, Shingo ^a   Mikami, Atsushi ^a   Higashi, Kenshi ^a   Baba, Shinya ^a   Shigemoto, Taeko ^b   Kuroda, Yasumasa ^b   Kanamori, Hiromitsu ^a   Amin, Mohamad ^b,c   Kawasaki, Masanori ^a   Nishigaki, Kazuhiko ^a   Taoka, Masato ^d   Isobe, Toshiaki ^d   Muramatsu, Chisako ^a   Dezawa, Mari ^b   Minatoguchi, Shinya ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c MANSOURA UNIVERSITY   (Egypt)

^d TOKYO METROPOLITAN UNIVERSITY   (Japan)

Author keywords

Bone marrow; Cell transplantation; Heart; Myocardial infarction; Stem cells

Indexed keywords

4 (2,6 DICHLORO 4 PYRIDINYL) 1 (1,3 DIMETHYL 4 ISOPROPYL 1H PYRAZOLO[3,4 B]PYRIDIN 6 YL)SEMICARBAZIDE; ALPHA ACTININ; BIOLOGICAL MARKER; CONNEXIN 43; GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN BASED CALCIUM CALMODULIN PROBE; SMALL INTERFERING RNA; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR 2; TRANSCRIPTION FACTOR GATA 4; TROPONIN I; UNCLASSIFIED DRUG; FUSION PROTEIN; LUCIFERASE; LYSOPHOSPHOLIPID; NANO-LANTERN PROTEIN; PHOTOPROTEIN; PYRAZOLE DERIVATIVE; PYRIDINE DERIVATIVE; S1PR2 PROTEIN, HUMAN; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE;

ACUTE HEART INFARCTION; ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOGRAFT; BONE MARROW CELL; CELL DIFFERENTIATION; CELL HOMING; CELL MIGRATION; CELL THERAPY; CONTROLLED STUDY; CONVALESCENCE; DIASTOLE; ENGRAFTMENT; FLUORESCENCE; GATA4 GENE; GENE SILENCING; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION SIZE; HUMAN; HUMAN CELL; JAPANESE WHITE (RABBIT); MALE; MESENCHYMAL STEM CELL; MULTILINEAGE DIFFERENTIATING STRESS ENDURING CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; SYSTOLE; TISSUE REPAIR; XENOGRAFT; ANIMAL; CELL MOTION; CYTOLOGY; GENETICS; GRAFT SURVIVAL; HEART INFARCTION; LEPORIDAE; METABOLISM; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; SPECIES DIFFERENCE; TRANSPLANTATION;

ALLOGRAFTS; ANIMALS; AUTOGRAFTS; CELL DIFFERENTIATION; CELL MOVEMENT; GATA4 TRANSCRIPTION FACTOR; GRAFT SURVIVAL; GREEN FLUORESCENT PROTEINS; HETEROGRAFTS; HUMANS; LUCIFERASES; LUMINESCENT PROTEINS; LYSOPHOSPHOLIPIDS; MALE; MYOCARDIAL INFARCTION; PLURIPOTENT STEM CELLS; PYRAZOLES; PYRIDINES; RABBITS; RECEPTORS, LYSOSPHINGOLIPID; RECOMBINANT FUSION PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SPECIES SPECIFICITY; SPHINGOSINE;

EID: 85053038823     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.117.311648     Document Type: Article

References (39)

1. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990;81:1161–1172.
2. George JC. Stem cell therapy in acute myocardial infarction: a review of clinical trials. Transl Res. 2010;155:10–19. doi: 10.1016/j.trsl. 2009.06.009.
3. Fisher SA, Zhang H, Doree C, Mathur A, Martin-Rendon E. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev. 2015;9:CD006536.
4. Kuroda Y, Kitada M, Wakao S, et al. Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci USA. 2010;107:8639–8643. doi: 10.1073/pnas.0911647107.
5. Wakao S, Kitada M, Kuroda Y, Shigemoto T, Matsuse D, Akashi H, Tanimura Y, Tsuchiyama K, Kikuchi T, Goda M, Nakahata T, Fujiyoshi Y, Dezawa M. Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts. Proc Natl Acad Sci USA. 2011;108:9875–9880. doi: 10.1073/ pnas.1100816108.
6. Kuroda Y, Wakao S, Kitada M, Murakami T, Nojima M, Dezawa M. Isolation, culture and evaluation of multilineage-differentiating stress-enduring (Muse) cells. Nat Protoc. 2013;8:1391–1415. doi: 10.1038/ nprot.2013.076.
7. Heneidi S, Simerman AA, Keller E, Singh P, Li X, Dumesic DA, Chazenbalk G. Awakened by cellular stress: isolation and characterization of a novel population of pluripotent stem cells derived from human adipose tissue. PLoS One. 2013;8:e64752. doi: 10.1371/journal.pone.0064752.
8. Kinoshita K, Kuno S, Ishimine H, Aoi N, Mineda K, Kato H, Doi K, Kanayama K, Feng J, Mashiko T, Kurisaki A, Yoshimura K. Therapeutic potential of adipose-derived SSEA-3-positive Muse cells for treating diabetic skin ulcers. Stem Cells Transl Med. 2015;4:146–155. doi: 10.5966/ sctm.2014-0181.
9. Alessio N, Özcan S, Tatsumi K, Murat A, Peluso G, Dezawa M, Galderisi U. The secretome of MUSE cells contains factors that may play a role in regulation of stemness, apoptosis and immunomodulation. Cell Cycle. 2017;16:33–44. doi: 10.1080/15384101.2016.1211215.
10. Hori E, Hayakawa Y, Hayashi T, Hori S, Okamoto S, Shibata T, Kubo M, Horie Y, Sasahara M, Kuroda S. Mobilization of pluripotent multilineage-differentiating stress-enduring cells in ischemic stroke. J Stroke Cerebrovasc Dis. 2016;25:1473–1481. doi: 10.1016/j. jstrokecerebrovasdis.2015.12.033.
11. Uchida H, Morita T, Niizuma K, Kushida Y, Kuroda Y, Wakao S, Sakata H, Matsuzaka Y, Mushiake H, Tominaga T, Borlongan CV, Dezawa M. Transplantation of unique subpopulation of fibroblasts, Muse cells, ameliorates experimental stroke possibly via robust neuronal differentiation. Stem Cells. 2016;34:160–173. doi: 10.1002/stem.2206.
12. Uchida H, Niizuma K, Kushida Y, Wakao S, Tominaga T, Borlongan CV, Dezawa M. Human Muse cells reconstruct neuronal circuitry in subacute lacunar stroke model. Stroke. 2017;48:428–435. doi: 10.1161/ STROKEAHA.116.014950.
13. Katagiri H, Kushida Y, Nojima M, Kuroda Y, Wakao S, Ishida K, Endo F, Kume K, Takahara T, Nitta H, Tsuda H, Dezawa M, Nishizuka SS. A distinct subpopulation of bone marrow mesenchymal stem cells, Muse cells, directly commit to the replacement of liver components. Am J Transplant. 2016;16:468–483. doi: 10.1111/ajt.13537.
14. Iseki M, Kushida Y, Wakao S, Akimoto T, Mizuma M, Motoi F, Asada R, Shimizu S, Unno M, Chazenbalk G, Dezawa M. Muse cells, nontumorigenic pluripotent-like stem cells, have liver regeneration capacity through specific homing and cell replacement in a mouse model of liver fibrosis. Cell Transplant. 2017;26:821–840. doi: 10.3727/096368916X693662.
15. Uchida N, Kushida Y, Kitada M, Wakao S, Kumagai N, Kuroda Y, Kondo Y, Hirohara Y, Kure S, Chazenbalk G, Dezawa M. Beneficial effects of systemically administered human Muse cells in adriamycin nephropathy. J Am Soc Nephrol. 2017;28:2946–2960. doi: 10.1681/ASN.2016070775.
16. Minatoguchi S, Takemura G, Chen XH, et al. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation. 2004;109:2572–2580. doi: 10.1161/01.CIR.0000129770.93985.3E.
17. Chen XH, Minatoguchi S, Kosai K, et al. In vivo hepatocyte growth factor gene transfer reduces myocardial ischemia-reperfusion injury through its multiple actions. J Card Fail. 2007;13:874–883. doi: 10.1016/j. cardfail.2007.07.004.
18. Ogura F, Wakao S, Kuroda Y, Tsuchiyama K, Bagheri M, Heneidi S, Chazenbalk G, Aiba S, Dezawa M. Human adipose tissue possesses a unique population of pluripotent stem cells with nontumorigenic and low telomerase activities: potential implications in regenerative medicine. Stem Cells Dev. 2014;23:717–728. doi: 10.1089/scd.2013.0473.
19. Saito K, Chang YF, Horikawa K, Hatsugai N, Higuchi Y, Hashida M, Yoshida Y, Matsuda T, Arai Y, Nagai T. Luminescent proteins for high-speed single-cell and whole-body imaging. Nat Commun. 2012;3:1262. doi: 10.1038/ncomms2248.
20. Metzler B, Hammerer-Lercher A, Jehle J, Dietrich H, Pachinger O, Xu Q, Mair J. Plasma cardiac troponin T closely correlates with infarct size in a mouse model of acute myocardial infarction. Clin Chim Acta. 2002;325:87–90.
21. Osada M, Yatomi Y, Ohmori T, Ikeda H, Ozaki Y. Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist. Biochem Biophys Res Commun. 2002;299:483–487.
22. Rosen H, Goetzl EJ. Sphingosine 1-phosphate and its receptors: an au-tocrine and paracrine network. Nat Rev Immunol. 2005;5:560–570. doi: 10.1038/nri1650.
23. Quint P, Ruan M, Pederson L, Kassem M, Westendorf JJ, Khosla S, Oursler MJ. Sphingosine 1-phosphate (S1P) receptors 1 and 2 coordinately induce mesenchymal cell migration through S1P activation of complementary kinase pathways. J Biol Chem. 2013;288:5398–5406. doi: 10.1074/jbc. M112.413583.
24. Ratajczak MZ, Suszynska M, Borkowska S, Ratajczak J, Schneider G. The role of sphingosine-1 phosphate and ceramide-1 phosphate in trafficking of normal stem cells and cancer cells. Expert Opin Ther Targets. 2014;18:95–107. doi: 10.1517/14728222.2014.851671.
25. Alijotas-Reig J, Llurba E, Gris JM. Potentiating maternal immune tolerance in pregnancy: a new challenging role for regulatory T cells. Placenta. 2014;35:241–248. doi: 10.1016/j.placenta.2014.02.004.
26. Hunt JS, Petroff MG, McIntire RH, Ober C. HLA-G and immune tolerance in pregnancy. FASEB J. 2005;19:681–693. doi: 10.1096/fj.04-2078rev.
27. Hou M, Yang KM, Zhang H, Zhu WQ, Duan FJ, Wang H, Song YH, Wei YJ, Hu SS. Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats. Int J Cardiol. 2007;115:220–228. doi: 10.1016/j.ijcard.2006.03.028.
28. Nagaya N, Fujii T, Iwase T, Ohgushi H, Itoh T, Uematsu M, Yamagishi M, Mori H, Kangawa K, Kitamura S. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol. 2004;287:H2670–H2676. doi: 10.1152/ajpheart.01071.2003.
29. Freyman T, Polin G, Osman H, Crary J, Lu M, Cheng L, Palasis M, Wilensky RL. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J. 2006;27:1114–1122. doi: 10.1093/eurheartj/ehi818.
30. Dar A, Kollet O, Lapidot T. Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. Exp Hematol. 2006;34:967–975. doi: 10.1016/j.exphem.2006.04.002.
31. Kawaguchi N, Smith AJ, Waring CD, Hasan MK, Miyamoto S, Matsuoka R, Ellison GM. c-kitpos GATA-4 high rat cardiac stem cells foster adult cardiomyocyte survival through IGF-1 paracrine signalling. PLoS One. 2010;5:e14297. doi: 10.1371/journal.pone.0014297.
32. Isner JM, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest. 1999;103:1231–1236. doi: 10.1172/JCI6889.
33. Mias C, Lairez O, Trouche E, Roncalli J, Calise D, Seguelas MH, Ordener C, Piercecchi-Marti MD, Auge N, Salvayre AN, Bourin P, Parini A, Cussac D. Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells. 2009;27:2734–2743. doi: 10.1002/stem.169.
34. Loffredo FS, Steinhauser ML, Gannon J, Lee RT. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell. 2011;8:389–398. doi: 10.1016/j. stem.2011.02.002.
35. Rizzo R, Bortolotti D, Bolzani S, Fainardi E. HLA-G molecules in autoimmune diseases and infections. Front Immunol. 2014;5:592. doi: 10.3389/ fimmu.2014.00592.
36. Drukker M, Katz G, Urbach A, Schuldiner M, Markel G, Itskovitz-Eldor J, Reubinoff B, Mandelboim O, Benvenisty N. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci USA. 2002;99:9864–9869. doi: 10.1073/pnas.142298299.
37. Kim EM, Manzar G, Zavazava N. Human iPS cell-derived hematopoietic progenitor cells induce T-cell anergy in in vitro-generated al-loreactive CD8(+) T cells. Blood. 2013;121:5167–5175. doi: 10.1182/ blood-2012-11-467753.
38. Nasef A, Mathieu N, Chapel A, Frick J, François S, Mazurier C, Boutarfa A, Bouchet S, Gorin NC, Thierry D, Fouillard L. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation. 2007;84:231–237. doi: 10.1097/01.tp.0000267918.07906.08.
39. Lila N, Amrein C, Guillemain R, Chevalier P, Latremouille C, Fabiani JN, Dausset J, Carosella ED, Carpentier A. Human leukocyte antigen-g expression after heart transplantation is associated with a reduced incidence of rejection. Circulation. 2002;105:1949–1954